98 studies found for:    Open Studies | "Dry Eye Syndromes"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Dry Eye Syndromes"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Syndrome
Intervention: Drug: dexamethasone, artificial tears
2 Recruiting Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Intervention: Drug: KPI-121
3 Recruiting Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
Condition: Dry Eye Syndromes
Interventions: Drug: Haporine-S;   Drug: Restasis (cyclosporine 0.05%)
4 Recruiting Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Conditions: Primary Sjogren Syndrome;   Secondary Sjogren Syndrome;   Aqueous Deficient Dry Eye Disease;   Evaporative Dry Eye Disease
Interventions: Drug: Restasis;   Drug: Refresh Endura
5 Unknown  Treatment of Dry Eye With Supplements
Condition: Dry Eye Syndromes
Intervention: Dietary Supplement: Vitamac® Tag and Nacht capsules
6 Recruiting A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: carboxymethylcellulose 0.5%/glycerin 0.9%;   Drug: sodium hyaluronate 0.18%
7 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
8 Recruiting Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: Oral Omega-3-acid ethyl esters;   Drug: Placebo corn oil capsule
9 Unknown  Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
Condition: Dry Eye Syndromes
Interventions: Drug: Altaire Gel forming solution;   Drug: Refresh Tears
10 Not yet recruiting Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients
Condition: Dry Eye Syndrome
Intervention: Device: Lacrima medical Prototypes
11 Recruiting Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
Condition: Dry Eye
Interventions: Drug: FML 0.1% eyedrops;   Drug: Liquifilm artificial tears eyedrops
12 Recruiting A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
Condition: Dry Eye Syndromes
Interventions: Drug: SI-614;   Drug: Vehicle
13 Recruiting A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)
Condition: Dry Eye Syndromes
Interventions: Drug: TheraTears® Lubricant Eye Drop;   Drug: TheraTears® preservative-free single-use containers;   Dietary Supplement: TheraTears® Nutrition;   Other: TheraTears® TheraLid® Eyelid Cleanser
14 Recruiting Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome
Conditions: Meibomian Gland Dysfunction;   Dry Eye Syndrome
Interventions: Device: Cutera Xeo Platform-Limelight;   Device: Sciton BroadBand Light
15 Recruiting Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye
Condition: Dry Eye Syndrome.
Interventions: Biological: Human nerve growth factor 20 µg/mL;   Biological: Human nerve growth factor 4 µg/mL or 60 µg/mL
16 Recruiting Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Device: T2762;   Device: Vismed®
17 Unknown  A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention: Drug: Essential fatty acid supplement
18 Recruiting Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: KL7016 900mg;   Drug: KL7016 600mg;   Drug: Placebo
19 Recruiting Civamide Nasal Solution for Dry Eye
Condition: Dry Eye
Intervention: Drug: Civamide Nasal Spray
20 Recruiting A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
Condition: Dry Eye
Intervention: Biological: RU-101

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years